Atlas Trials

An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without Diabetes

Clinical trial NCT00576667 · TERMINATED

Trial details

NCT number
NCT00576667
Sponsor
Sanofi
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Fatty Liver
Start date
2008-01-01
Primary completion
2009-02-01
Enrollment
165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.